Left ventricular hypertrophy (LVH) potentiates reperfusionassociated ventricular fibrillation. To study the mechanism responsible, patch-clamp techniques were used to evaluate transmembrane ionic currents during "reperfusion" after a CN --induced metabolic surrogate for ischemia in isolated myocytes from a feline model of experimental LVH. Reperfusion caused the generation of early afterdepolarizations (EADs) from an average take-off potential of -33 mV in LVH cells but not in cells from normal hearts. 10 min after initiating reperfusion of normal cells, action potential duration (APD) at 50% repolarization (APDTO) lengthened from 198±41 to 233±57 ms whereas in LVH cells APDjo lengthened from 262±84 to 349±131 ms (P < 0.05). Among the LVH cells, APDjo lengthening was significantly greater in the cells that had developed EADs. During reperfusion, steady state outward current in the voltage range of the action potential plateau (between -20 and +20 mV) was reduced from the control values in LVH cells but not in normal cells. Reperfusion-related reduction of steady state outward current in LVH cells was abolished under experimental conditions in which L-type Ca2+ current was isolated from other classes of currents whereas it was still observed under the condition in which pure K+ currents could be recorded. Thus, reduction of steady state outward current due to the reduction of outward K+ current over the action potential plateau voltage range appears to be responsible for an excessive prolongation of APD, leading to the development of EADs. (J. Clin. Invest. 1993. 91:1521-1531
Introduction
Cardiac hypertrophy is a common physiological response to chronic pressure overload and is characterized by cellular enlargement accompanied by biochemical (1), electrophysiological (2, 3) , and mechanical changes (4), as well as alterations in the coronary circulation (5) . Although left ventricular (LV)1 hypertrophy is an adaptive process permitting maintenance of physiological function in the face of increased work loads, it may enhance some deleterious effects ofischemia. When acute ischemia occurs in dogs with LV hypertrophy, the incidence of lethal arrhythmias and sudden cardiac death increases markedly (6) . Several experimental studies demonstrated enhanced susceptibility of the hypertrophied heart to ischemic arrhythmias, and an enhanced propensity to reentrant arrhythmias has been suggested (6) (7) (8) . Kohya et al. (7) reported in multicellular ventricular muscle preparations that tissues isolated from hypertrophied LV showed a greater degree of shortening ofaction potential duration (APD) during acute regional ischemia than did normal tissues. They suggested that this would tend to enhance dispersion of refractoriness during ischemia, between the shortened APD in the ischemic zone and the prolonged APD of the hypertrophied nonischemic zone, and would enhance the propensity to reentrant arrhythmias during ischemia. Martins et al. (8) suggested that hypertrophied hearts had a higher inducibility of ventricular tachycardia. Such hearts displayed greater endocardial-to-epicardial conduction delay in ischemic zones and responses of induced ventricular tachycardia to stimulation met two criteria for entrainment; both findings were consistent with reentrant tachycardia.
Recently, however, Taylor et al. (9) reported in an in vivo study that LV hypertrophy potentiated reperfusion-associated ventricular fibrillation (VF). Potentiation of reperfusion-associated VF, in addition to the enhanced susceptibility to ischemic arrhythmias in LV hypertrophy, may provide additional explanations for greater susceptibility of patients with LV hypertrophy to sudden cardiac death. The mechanisms for reperfusion arrhythmias have not been fully elucidated but, in contrast to ischemic arrhythmias, it has been suggested that nonreentrant mechanisms, such as automaticity or afterdepolarization-induced triggered activity, may have a prominent role (10, 11) . Furthermore, Molina-Viamonte et al. (12) suggest that a specific alpha-adrenergic pathway, which induces phosphoinositide metabolism, is involved in the generation of triggered activity during reperfusion.
Delayed repolarization with prolonged APDs occurs in LV hypertrophy, a pathphysiological feature favoring the generation of early afterdepolarizations (EADs) (11) . Therefore, the present study was designed to test the hypothesis that hypertrophied LV myocytes are more susceptible to development of EADs during reperfusion after an ischemic surrogate than are normal myocytes. Since EADs occur during reperfusion, patch-clamp experiments were done to characterize the ionic mechanisms responsible for reperfusion-associated EADs in hypertrophied myocytes. A preliminary report ofthis work has been presented (13) .
guidelines by the National Institutes of Health and the Department of Agriculture.
Preparations ofanimals and surgicalprocedure. Hypertension with secondary cardiac hypertrophy was induced in adult mongrel cats by chronic pressure overload produced by a modification of a subtotal subdiaphragmatic aortic stenosis procedure described previously ( 14) . In 28 cats (wt 2.5-4.5 kg; mean 3.4±0.6 kg) of either sex, general anesthesia was induced with 5% isoflurane and 02 flowing at 1 liter/ min using an isoflurane-specific vaporizer ( Using standard sterile techniques, the abdomen was entered through a midline incision, the abdominal aorta was dissected, and a nonabsorbable polytetrafluoroethylene-coated polyester tie (0 Ethiflex) was looped around the aorta just cranial to the renal arteries. A tie was made to constrict the aorta to -10% ofthe original surface diameter; this usually increased systolic blood pressure in the right brachial artery, monitored during general anesthesia, by [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] 50 ,M Ca2". Enzymatic perfusion was continued until the solution flowed freely ( 12-15 min) . The heart was then removed from the Langendorff apparatus. The LV was separated from the atria and the right ventricle, small pieces of the endocardial surface of the LV free wall were dissected using a fine scissors, and single cells were obtained by gentle agitation oftissue pieces in a beaker containing nominally Ca2 -free Tyrode's solution. Cells were filtered through 300-,um nylon mesh, washed with Tyrode's solution containing increasingly higher concentrations of Ca2" (0-2 mM CaCl2), and stored in Tyrode's solution containing 2 connections to the pipette and to the bath were made through Ag-AgCl half-cell electrodes. The electrode potential was adjusted to zero current between the internal pipette solution and the external (bath) solution immediately before each cell was approached. Single cells were drawn onto the tip ofthe pipette by gently pressing the tip onto the cell surface. After a seal resistance of 10-100 GQ was established by gentle suction ( 10-30 cm water), the cell membrane under the electrode tip was broken by further application of negative pressure. A resting membrane potential (RMP) of -75 mM to -90 mV was recorded in > 90% of the cells. Whole-cell current and membrane potential were recorded through a patch-clamp amplifier (model 8900; Dagan Corp.). Action potentials were elicited under current-clamp conditions by passing depolarizing current pulses of suprathreshold intensity (< 2 ms in duration) through the pipette at a rate of 0.5 or 1 Hz. The membrane current was measured in the voltage-clamp mode and by applying various protocols of pulses as indicated in the text. Electrode resistance in series with the cell membrane was compensated by minimizing the duration of the capacitive surge on the current trace. Capacitive currents were measured during the application of 10-mV hyperpolarizing pulses, and the area under the capacity transient (Imp) was integrated and used as a measure ofwhole cell membrane area (Am), assuming a specific membrane capacity of 1 1uF/cm2 (18) . To avoid the confounding influence of difference in cell size between normal and pressure-overloaded cells, the amplitude of membrane currents were normalized to cell capacitance and expressed as pA/pF.
The stability of each preparation was verified before experimental measurements. For the experiments in which action potentials were recorded, verification was obtained by monitoring action potentials at a drive rate of 1 Hz for a 20-min equilibration period. For the experiments in which Ca 2+ currents were recorded, membrane currents were recorded during 800-ms depolarizing pulses from a holding potential (Vh) of-40 mV to a test potential (Vt) of0 mV at a drive rate of0.5 Hz for a 10-min equilibration period. For the experiments in which noni-1522 solated currents or K+ currents were recorded, membrane currents were monitored during 800-ms depolarizing pulses from a Vh of -80 mV to a J' of +30 mV, at a rate of 0.5 Hz for a 10-min equilibration period. The preparations were considered stable if the APD at 0 mV (APDO mV), the amplitude of the negative peak of IC,,L, or the amplitude of steady state outward currents in each case did not differ by > 5% of their initial values in successive measurements. Once a stable condition was established, the specific experiments were initiated, and the preparations were maintained without significant deterioration or electrical changes for 30-40 min. Therefore, all electrophysiological studies were completed within 30 min.
To induce metabolic inhibition and simulate "ischemia," cells were exposed to CN - ( 19, 20) . The bath was superfused with Tyrode's solution containing 1 mM CN-, and action potentials or membrane currents were monitored for up to 15 min. The bath was thereafter reperfused with normal Tyrode's solution and action potentials or membrane currents were monitored for up to 10 min. CN--Tyrode's solution was prepared by omitting glucose and adding 1 mM NaCN to the Tyrode's solution, and pH was adjusted to 7.4 with HCL. Action potentials were recorded continuously and membrane currents were recorded every 5 min.
Data analysis. Membrane potentials were monitored on an oscilloscope and digitized on-line with a 14.4-bit resolution A/D converter (model PCM-1; Medical Systems Corp., Greenvale, NY) and stored on a videocassette recorder (model SL-HF900; Sony, Tokyo, Japan). Membrane currents were digitized on-line through a 12-bit resolution Labmaster A/ D converter (TecMar Scientific Solutions, Burlingame, CA) under the control of an IBM-AT computer and were stored on a floppy disc. Data were analyzed using the pClamp software program (Axon Instruments, Inc., Burlingame, CA).
All data were expressed as mean±SEM. Student's unpaired t test was used to evaluate the statistical significance ofdifferences in characteristics of experimental animals and those of action potentials in the control state between normal and hypertrophy groups. Effects ofmetabolic inhibition or reperfusion were analyzed with one-way analysis of variance with repeated measures, followed by the Newman-Keuls test. Statistical significance of binomial responses was evaluated with Fisher's exact test. Differences with P < 0.05 were considered significant.
Results
Characteristics ofexperimental animals. Physiological and anatomical characteristics of normal and pressure-overloaded animals are summarized in Table I . Systolic blood pressure (carotid artery) and the systolic pressure gradient between the carotid and femoral arteries were significantly higher in pressure-overloaded animals than in normal animals. Total heart weight and the ratio of total heart weight to body weight Effects ofreperfusion on characteristics ofaction potentials.
We compared characteristics of action potentials during metabolic inhibition and during reperfusion between normal and hypertrophied cells. Because EADs were observed more frequently at a driving rate of0.5 Hz than at 1.0 Hz, the following analyses were performed using data recorded at a drive rate of 0.5 Hz. Characteristics of action potentials before exposure to CN-(control) are summarized in Table III . APD was significantly longer in cells isolated from hypertrophied hearts than those from normal hearts whereas neither RMP nor action potential amplitude (APA) was significantly different between the two cell types.
Representative recordings of action potentials in a normal cell and a hypertrophied cell before and during exposure to CN-and during reperfusion are shown in Fig. 2 . In both normal and hypertrophied cells, APD was shortened during superfusion with CN--Tyrode's solution, and was prolonged during reperfusion with normal Tyrode's solution. In Fig. 3 4 and Table V) . We also studied the characteristics of action potentials before exposure to CN-(basal values), comparing hypertrophied cells that had developed EADs during reperfusion to those that had not. Under baseline conditions, the APDs of hypertrophied cells that had developed EADs during reperfusion had longer durations whereas neither RMP nor APA was significantly different between the two cell types. Control APD9I was 376±46 ms in hypertrophied cells with EADs (n = 4) versus 265±18 ms in those without EADs (n = 10) (P < 0.01); the corresponding values for APD50 were 346±45 and 235±17 ms, respectively (P < 0.01).
Effects ofreperfusion on membrane currents. To elucidate ionic mechanisms underlying greater APD prolongation and higher incidence of EAD development in hypertrophied myocytes during reperfusion, voltage-clamp studies were carried out under several experimental conditions. Nonisolated membrane currents were first elicited by 800-ms-long steps from a Vh of -80 mV to various test potentials (Vi) between -90 and +60 mV in 10-mV steps. Fig. 5 A displays representative tracings at a V, of -1O mV for a normal cell (top) and a hypertrophied cell (bottom). In both cell types, superfusion with CN--Tyrode's solution shifted membrane current positively (marked by closed squares) whereas reperfusion with normal Tyrode's solution shifted membrane current negatively (indicated by open circles). During reperfusion with normal Tyrode's solution, in normal cells, membrane current was slightly more positive than the control level whereas in hypertrophied cells reperfusion shifted membrane current more negative than the control level. The current level 600 ms after the onset ofthe voltage steps was measured because this was the approximate timing of EAD development (the mean coupling interval between the action potential upstroke and the peak voltage of 50 mV [ 
sec
EADs was 592±90 ms). Fig. 5 B shows the averaged currentto-voltage (I-V) relationships obtained using the current density (the amplitude normalized to cell membrane capacitance) in the control state, 15 min after initiating superfusion with CN--Tyrode's solution, and 10 min after initiating reperfusion with normal Tyrode's solution for normal cells (n = 18, left) and for hypertrophied cells (n = 16, right). In both normal and hypertrophied cells, during superfusion with CN--Tyrode's solution, inward current at a Vt of -90 mV decreased whereas outward current at Vt more positive than -30 mV increased; however, the magnitude of these changes in the steady state I-V curve was not significantly different between the two cell types. During reperfusion with normal Tyrode's solution, in both normal and hypertrophied cells, inward current at a Vt of -90 mV in the steady state I-V curve increased and returned close to the control values. Outward current at Vt more positive than -30 mV decreased and returned close to the control level in normal cells whereas in hypertrophied cells outward current decreased to values less than the control level at Vt between -20 and +20 mV (marked by asterisks in Fig. 5 B) .
Effect of reperfusion on Ca2`currents. Many classes of currents, including L-type Ca2`current (ICAL) and several K+ currents, contribute to the configuration ofthe action potential plateau and might be responsible for negative shift of steady state currents over the voltage range of the action potential plateau during reperfusion of hypertrophied cells. We first compared alterations in I'QL during reperfusion between normal and hypertrophied cells. To isolate ICL, we substituted TEA+ for Na+ and added 12.5 ,M TTX to the bath solution to block Na' current (INa). K+ currents were eliminated with internal CsCl2 (130 mM) and external TEA-Cl ( 140 mM). The pipette solution was free of CaCI2 and was buffered with 10 mM EGTA to minimize the contribution of Ca2+-activated currents and Na'-Ca2+ exchange currents. 10 IAM ouabain was added to the bath solution to eliminate currents through Na+-K' pump. To elicit ICL, Vh was set at -40 mV to inactivate INa and T-type Ca2+ currents (ICh,T ) (if present), and the membrane potential was clamped for 800 ms to a Vt between -90 and +50 mV in 10-mV steps at intervals of 2 s. Fig. 6 A displays representative tracings ofthe early portions of I L for a normal cell (top) and for a hypertrophied cell (bottom) to assess changes in the negative peak current. In both cell types, the amplitude ofIC,L decreased during superfusion with CN--Tyrode's solution whereas during reperfusion with normal (Fig. 7 A) . Fig. 7 negative than the control level. Fig. 8 Fig. 8 B) .
Discussion
The Before discussing the relevance of the data in the present study, some characteristics of the study protocol must be considered. In in vivo experiments the incidence of reperfusion arrhythmias is directly dependent on the duration of the ischemia period ( 1 1, 13) . In the feline model of occlusion-reperfusion, the incidence of reperfusion-associated VF was relatively high (47-62%), with reperfusion established after 20 min of coronary occlusion whereas it was significantly less after a 10-min occlusion ( 13%) (23) . In the current studies we used 15 min of metabolic inhibition before reperfusion. This period was chosen because transmembrane action potentials and The severity of metabolic inhibition may also influence the incidence of reperfusion arrhythmias. In the present experiments we used 1 mM CN-to induce metabolic inhibition. In previous experiments we had observed that exposure to relatively high-concentration CN-(5 mM) shortened APD excessively and created a sharply spiked action potential configuration, with elimination ofthe plateau phase, in both normal and hypertrophied cells (24). In contrast, the shortening of APD during exposure to 1 mM CN-for up to 20 min was more moderate, but the magnitude of decrease was significantly greater in hypertrophied cells than normal cells. Thus, our data may be relevant for reperfusion arrhythmias after a relatively mild metabolic inhibition for a short time period, a condition that may be similar to some clinical circumstances in which coronary artery spasm induces arrhythmias as a result of either ischemia, reperfusion, or both (25). In experiments with longer or more severe degrees ofmetabolic inhibition, the development of EADs might be more frequent and they may occur even in normal cells.
Reperfusion of the ischemic myocardium is frequently associated with the development of malignant ventricular arrhythmias (23) . A recent in vivo experiment demonstrated that LV hypertrophy enhanced the development of reperfusion-associated VF (9). Taylor et al. (9) demonstrated that reperfusion-associated VF occurred in 7 of 17 dogs (41% ) with LV hypertrophy versus 1 of28 dogs (6%) without hypertrophy. Although the mechanisms for reperfusion arrhythmias have not been fully elucidated, it has been suggested that nonreentrant mechanisms, including afterdepolarization-induced triggered activity, may have a predominant role (10-12). The characteristics of some forms of reperfusion arrhythmias observed clinically support this concept ( 25 ), especially after relatively brief periods of ischemia. The present study demonstrates that single myocytes isolated from hypertrophied ventricles are highly susceptible to development of EADs during reperfusion after the metabolic inhibition surrogate for ischemia. In addition to the possibly greater propensity of hypertrophied hearts to ischemia-induced reentrant arrhythmias, the enhanced propensity to generate reperfusion-induced EAD may partially underlie the susceptibility of patients with LV hypertrophy to sudden cardiac death, although our single-cell study design precluded reentrant mechanisms.
One may question the discrepancy between the timing between the onset of EADs in the present study and the onset of reperfusion arrhythmias in in vivo studies. In the clinical setting or in vivo experiments, reperfusion arrhythmias start to occur within several seconds after the coronary circulation is reestablished (11) . In the present study, however, the mean time interval between the initiation of reperfusion and the onset of EADs development was 3.4 min (range 2.1-5.7 min). This time discrepancy could be accounted by the differences in conditions between the in vivo and the in vitro studies. Priori et al. (23) observed in vivo that reperfusion-induced EADs started to occur at the moment of reperfusion whereas Ferrier et al. (26) reported in an in vitro study that reperfusion-induced delayed afterdepolarizations were initiated 5.3±0.6 min after reperfusion. The loss of autonomic nervous innervation in vitro may influence the time frame of onset of reperfusion arrhythmias, since alpha- (27) and beta-adrenergic (28) stimulation enhances the amplitude and incidence of cesium-induced EADs. As suggested previously, reperfusion arrhythmias may be based on multiple underlying mechanisms, and earlier onset of reperfusion arrhythmias could simply be reflecting mechanisms different from the relatively delayed onset of EADs observed in our study. In fact, abrupt reperfusion of ischemic myocardium results in an initial shortening of refractory period within seconds, whereas with sustained reperfusion of > 30 s, refractory periods and APD in the previously ischemic region lengthen beyond preischemic values (29) . EADs can be induced in isolated tissue by a variety of interventions that lengthen APD, providing a condition that permits the cellular membrane to carry the depolarizing charge through inward current channels that have recovered from inactivation. The data in the present study reinforce the importance of The lengthening of APD should reflect the sum of the lengthening of APD for the generation of EADs. In cells isocurrents that flow within voltage range of the action potential lated from normal hearts, APD was slightly prolonged during plateau. These include Na+ "window" current or slowly inactireperfusion. This finding is in agreement with the data in mulvating Na' current (30, 3 1 ), Ca2" current (32, 33) , K+ current ticellular ventricular muscle preparations or in vivo (23, 28) ; (34) (35) (36) (37) (38) , and possibly Na'-K' pump (39) and Na'-Ca2' exrefractory periods and APDs in the previously ischemic region change current (40 (43) reported in an in vivo study that susceptibility to VF induced by electrical stimulation was markedly enhanced in cats with pressure overload compared with the control group. Risotilide, an inhibitor ofthe voltage-dependent K+ channel, but not verapamil, reduced ventricular vulnerability concomitant with narrowed dispersion of the effective refractory period and monophasic action potential duration, suggesting reentry as a possible mechanism underlying electrically induced VF in cat ventricular hypertrophy. Thus, although alterations in K+ channels appear to be a significant factor for the development of both electrically induced VF and reperfusion-related EADs, the arrhythmogenic mechanism involving K+ channels in hypertrophied hearts may be different between the two cases. It should be noted that, even though our data suggest that IC' L may not be a primary factor for APD prolongation during reperfusion in hypertrophied cells, the contributions of Na' current, ICaT, Na'-Ca2+ exchanges, or Na'-K' pump current were not completely excluded and require further study.
The negative shift of steady state outward K+ current was prominent at a V, range between -30 and +20 mV (see Fig. 8 B (47) . In summary, the data reported in this study are consistent with an evolving body of information leading to a general principle of the association between various factors that prolong APDs and lead to generation of EADs. Triggered activity resulting from EADs appears to lead to specific forms of clinical arrhythmias, such as torsades de pointes, rapid polymorphic VT, and possibly ventricular fibrillation. In such diverse clinical circumstances as classical proarrhythmic responses to class I-A and III antiarrhythmic drugs (48, 49) , acute cocaine exposure (50) , and now reperfusion after ischemia in cells from hypertrophied hearts, the conditioning event, APD prolongation, appears to be due primarily to abnormalities in repolarizing K+ currents (especially Ik) whereas the EADs themselves are generated by Ca2" (or perhaps slowly inactivating Na') acting as the carrier current.
